Skip Ribbon Commands
Skip to main content
Translate
Donations
menu iconMenu
search iconSearch

Ferrara Receives Gairdner Prize, Canada’s Highest Honor in Life Sciences

Honored for research leading to new therapies for cancer and wet macular degeneration

March 26, 2014  |  

Napoleone Ferrara, MD, distinguished professor of pathology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today among eight recipients of the Canada Gairdner Awards at a ceremony in Toronto.

Ferrara 

Napoleone Ferrara, MD

The Gairdner awards are among the most esteemed honors in medical research, celebrating  outstanding discoveries or contributions to medical and life sciences. This year’s awards showcase achievements in cardiovascular disease, cancer, immunotherapy and human parasitic diseases.

Ferrara was recognized for his work identifying the role of the human VEGF gene in promoting angiogenesis – the formation of new blood vessels that can feed tumor growth – and subsequent development of two major monoclonal antibody drugs: Bevacizumab (marketed as Avastin), which is used to treat multiple forms of cancer, including breast, brain and colorectal, and ranibizumab (marketed as Lucentis), which treats wet age-related macular degeneration, a leading cause of blindness in the elderly.

Other 2014 recipients are James P. Allison, PhD, of the University of Texas MD Anderson Cancer Center for developing immune system-based cancer therapies; Titia de Lange, PhD, of Rockefeller University for her discovery of the mechanisms protecting mammalian telomeres from damage; Sir Marc Feldman, FRS, and Sir Ravinder Nath Maini, FRS, of the University of Oxford for their discovery of a new rheumatoid arthritis treatment; Harold Fisher Dvorak, MD, of Harvard Medical School for his work describing how cancer tumors make VEGF; Satoshi Omura, PhD, of Kitasato University for identifying the causative microorganisms of  river blindness and helping develop a successful treatment; and Salim Yusuf, MBBS, of David Braley Research Institute for his extensive epidemiological cardiovascular studies in more than 60 countries. 

The Gairdner awards have been presented by the Gairdner Foundation since 1959, and are  sometimes a precursor to later Nobel Prizes. Each award comes with a $100,000 stipend in Canadian dollars. The awards will be formally presented at a dinner in Toronto in late October. 

# # #

Media contact: Scott LaFee, 619-543-6163, slafee@ucsd.edu




Media Contact

Related News

5/8/2015
Therapies that specifically target mutations in a person’s cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers at University of ...
2/13/2015
While genomics is the study of all of the genes in a cell or organism, epigenomics is the study of all the genomic add-ons and changes that influence gene expression but aren’t encoded in the DNA sequ ...
1/22/2015
Researchers at University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and the Bridge Institute at the University of Southern California report the first crystal stru ...
1/20/2015
Upending decades-old dogma, a team of scientists at the University of California, San Diego School of Medicine say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that ...
10/23/2014
In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the ...
10/20/2014
UC San Diego Sanford Stem Cell Clinical Center is pushing therapeutic stem cell-based science out of the laboratory and closer to real-world medical applications. The unprecedented trials involve pote ...
9/16/2014
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with ...
9/10/2014
Napoleone Ferrara, MD, Distinguished Professor of Pathology and Distinguished Adjunct Professor of Ophthalmology at the University of California, San Diego School of Medicine and senior deputy directo ...


Share This Article



Follow Us